These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12622011)

  • 1. [Continuous subcutaneous infusion in palliative care, an undervalued method].
    Keijer WJ; de Jong RJ
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):318-9; author reply 319. PubMed ID: 12622011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Continuous subcutaneous infusion in palliative care, an undervalued method].
    Smulders YM
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):319; author reply 319. PubMed ID: 12622012
    [No Abstract]   [Full Text] [Related]  

  • 3. [Continuous subcutaneous infusion in palliative care, an undervalued method].
    van Marum RJ; de Vogel EM; Zylicz Z
    Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2221-4. PubMed ID: 12481516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical morphine for cutaneous cancer pain.
    Krajnik M; Zylicz Z
    Palliat Med; 1997 Jul; 11(4):325. PubMed ID: 9373587
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: a nursing perspective.
    Derby S
    J Pain Symptom Manage; 1998 Aug; 16(2):134. PubMed ID: 9737106
    [No Abstract]   [Full Text] [Related]  

  • 6. Physical compatibility of binary and ternary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care.
    Destro M; Ottolini L; Vicentini L; Boschetti S
    Support Care Cancer; 2012 Oct; 20(10):2501-9. PubMed ID: 22252547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
    Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
    Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of continuous ambulatory infusions of concentrated subcutaneous (s.q.) hydromorphone versus intravenous (i.v.) morphine: cost implications for palliative care.
    Fudin J; Smith HS; Toledo-Binette CS; Kenney E; Yu AB; Boutin R
    Am J Hosp Palliat Care; 2000; 17(5):347-53. PubMed ID: 11886060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion.
    Schneider JJ; Good P; Ravenscroft PJ
    J Pain Symptom Manage; 2006 Jun; 31(6):563-7. PubMed ID: 16793496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parenteral opioids in end-of-life care in cancer patients].
    Hattori S; Kimura N; Takatani J; Noguchi T
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):161-6. PubMed ID: 15751626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting from oral morphine to subcutaneous diamorphine.
    Amesbury B
    Palliat Med; 2000 Mar; 14(2):165-7. PubMed ID: 10829155
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid medication in the palliative care of motor neurone disease.
    Oliver D
    Palliat Med; 1998 Mar; 12(2):113-5. PubMed ID: 9616447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National survey of drug use in palliative care.
    Drummond SH; Peterson GM; Galloway JG; Keefe PA
    Palliat Med; 1996 Apr; 10(2):119-24. PubMed ID: 8800819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous morphine infusions for cancer pain in resource-scarce environments: comparison of the subcutaneous and intravenous routes of administration.
    Koshy RC; Kuriakose R; Sebastian P; Koshy C
    J Pain Palliat Care Pharmacother; 2005; 19(1):27-33. PubMed ID: 15814512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous sufentanil for palliative care patients in a hospital setting.
    White C; Hardy J; Boyd A; Hall A
    Palliat Med; 2008 Jan; 22(1):89-90. PubMed ID: 18216082
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicating "Margaret".
    Reid C
    J Clin Ethics; 2006; 17(4):340-3. PubMed ID: 17330727
    [No Abstract]   [Full Text] [Related]  

  • 17. [Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan].
    Hashizume T; Tomiyasu S; Yomiya K; Yoshimoto T; Harada A; Matoba M;
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):897-902. PubMed ID: 17570968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
    Morita T; Takigawa C; Onishi H; Tajima T; Tani K; Matsubara T; Miyoshi I; Ikenaga M; Akechi T; Uchitomi Y;
    J Pain Symptom Manage; 2005 Jul; 30(1):96-103. PubMed ID: 16043013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral morphine prescribing patterns among inpatients with pain from advanced cancer: a prospective survey of intravenous and subcutaneous use.
    Walsh D; Perin ML; McIver B
    Am J Hosp Palliat Care; 2006; 23(5):353-9. PubMed ID: 17060302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midazolam as adjunct therapy to morphine to relieve dyspnea?
    Sironi O; Sbanotto A; Banfi MG; Beltrami C
    J Pain Symptom Manage; 2007 Mar; 33(3):233-4; author reply 234-6. PubMed ID: 17349490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.